Listed
Stock Code: 191420
| Company Name | 테고사이언스(주) |
| English Name | Tego Science, Inc. |
| Business Reg. No. | 3148140292 |
| CEO | 전세화 |
| Address | 서울특별시 강서구 마곡중앙8로 93 (마곡동, 테고사이언스) |
| Industry | 기초 의약 물질 제조업 |
| Industry Code | 211 |
| Main Products | 피부세포치료제 제조,도매,연구개발 |
| Established | 20010320 |
| Phone | 02-818-2900 |
| Website | www.tegoscience.com |
| Regular Employees | 42persons |
| Corp. Reg. No. | 1601110114126 |
Venture Certified
| 신기술기업(산업지원서비스업) | 2001-03-30 ~ 2003-03-29 | 011135033108569 | 2001-03-30 |
| 연구개발기업 | 2003-03-12 ~ 2005-03-11 | 031135021200314 | 2001-03-30 |
| 연구개발기업 | 2005-03-12 ~ 2007-03-11 | 051135021300472 | 2001-03-30 |
| 벤처투자유형 | 2007-03-12 ~ 2008-03-11 | 20070300101 | 2001-03-30 |
| 벤처투자유형 | 2008-03-12 ~ 2009-03-11 | 20080300103 | 2001-03-30 |
| 벤처투자유형 | 2009-03-12 ~ 2010-03-11 | 20090300049 | 2001-03-30 |
| 벤처투자유형 | 2010-03-12 ~ 2012-03-11 | 20100300054 | 2001-03-30 |
| 벤처투자유형 | 2012-03-12 ~ 2014-03-11 | 20120300108 | 2001-03-30 |
| 벤처투자유형 | 2014-03-12 ~ 2016-03-11 | 20140300090 | 2001-03-30 |
| 벤처투자유형 | 2016-03-12 ~ 2018-03-11 | 20160300081 | 2001-03-30 |
| 연구개발유형 | 2018-03-12 ~ 2020-03-11 | 20180102686 | 2001-03-30 |
| 연구개발유형 | 2020-03-12 ~ 2022-03-11 | 20200102673 | 2001-03-30 |
| 연구개발유형 | 2022-03-12 ~ 2025-03-11 | 20220331020032 | 2001-03-30 |
| 연구개발유형 | 2025-03-12 ~ 2028-03-11 | 20250318020021 | 2001-03-30 |
Revenue CAGR -6.6%
| Item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 68B | 78B | 77B | 83B |
| Operating Profit | -22B | -12B | 2.1B | -1.0B |
| Net Profit | 33B | -23B | 2.6B | 0.5B |
| Total Assets | 525B | 489B | 514B | 510B |
| Total Liabilities | 28B | 26B | 29B | 26B |
| Total Equity | 497B | 463B | 485B | 484B |
Operating Loss: Op. profit -22B
▼ 14.6%
▼ 521.6%
▼ 620.7%
▲ 0.5%
▲ 551.8%
| Name | Position | Role |
|---|---|---|
| 전세화 | 사내이사 | 총괄 사장 |
| 전재욱 | 사내이사 | 전략 기획 |
| 이진우 | 사외이사 | 사외 이사 |
| 장한규 | 사내이사 | 생산 총괄 |
| 정성인 | 감사 | 감사 |
| NPS Subscribers | 38persons |
| CEO | 전세화 |
| Est. Avg. Annual Salary | 4,51110K (37610K/mo) |
| Hired (12 mo) | +0persons |
| Left (12 mo) | -1persons |
| Net Change (12 mo) | -1persons |
| NPS Join Date | 2001-03-20 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "서울특별시 강서구 마곡중앙8로",
"brno": "314814****",
"cappedWarning": false,
"companyName": "테고사이언스(주)",
"estimatedAvgAnnualSalary": 45114816,
"estimatedAvgMonthlySalary": 3759568,
"fetchedAt": "2026-03-05T11:07:29.891Z",
"industryCode": "331100",
"industryName": "전기식 진단 및 요법 기기 제조업",
"joinDate": "20010320",
"last12MonthsHired": 0,
"last12MonthsLeft": 1,
"last12MonthsNetChange": -1,
"leaveDate": null,
"monthlyPensionAmount": 13572040,
"monthlyTrend": [
{
"lostSubscribers": 1,
"newSubscribers": 0,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6683143",
"status": "1",
"styleCode": "1",
"subscriberCount": 38,
"turnoverMonths": 1
}{
"address": "서울 강서구",
"ceo_name": "전세화",
"certificate": [
{
"cert_number": "011135033108569",
"changes": "",
"disclosure_date": "2001-03-30",
"first_cert_date": "2001-03-30",
"no": "1",
"type": "신기술기업(산업지원서비스업)",
"valid_period": "2001-03-30 ~ 2003-03-29"
},
{
"cert_number": "031135021200314",
"changes": "",
"disclosure_date": "2003-03-12",
"first_cert_date": "2001-03-30",
"no": "2",
"type": "연구개발기업",
"valid_period": "2003-03-12 ~ 2005-03-11"
},
{
"cert_number": "051135021300472",
"changes": "",
"disclosure_date": "2005-03-12",
"first_cert_date": "2001-03-30",
"no": "3",
"type": "연구개발기업",
"valid_period": "2005-03-12 ~ 2007-03-11"
},
{
"cert_number": "20070300101",
"changes": "",
"disclosure_date": "2007-03-15",
"first_cert_date": "2001-03-30",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2007-03-12 ~ 2008-03-11"
},
{
"cert_number": "20080300103",
"changes": "",
"disclosure_date": "2008-02-28",
"first_cert_date": "2001-03-30",
"no": "5",
"type": "벤처투자유형",
"valid_period": "2008-03-12 ~ 2009-03-11"
},
{
"cert_number": "20090300049",
"changes": "",
"disclosure_date": "2009-02-26",
"first_cert_date": "2001-03-30",
"no": "6",
"type": "벤처투자유형",
"valid_period": "2009-03-12 ~ 2010-03-11"
},
{
"cert_number": "20100300054",
"changes": "",
"disclosure_date": "2010-02-25",
"first_cert_date": "2001-03-30",
"no": "7",
"type": "벤처투자유형",
"valid_period": "2010-03-12 ~ 2012-03-11"
},
{
"cert_number": "20120300108",
"changes": "",
"disclosure_date": "2012-03-29",
"first_cert_date": "2001-03-30",
"no": "8",
"type": "벤처투자유형",
"valid_period": "2012-03-12 ~ 2014-03-11"
},
{
"cert_number": "20140300090",
"changes": "",
"disclosure_date": "2014-03-13",
"first_cert_date": "2001-03-30",
"no": "9",
"type": "벤처투자유형",
"valid_period": "2014-03-12 ~ 2016-03-11"
},
{
"cert_number": "20160300081",
"changes": "",
"disclosure_date": "2016-03-10",
"first_cert_date": "2001-03-30",
"no": "10",
"type": "벤처투자유형",
"valid_period": "2016-03-12 ~ 2018-03-11"
},
{
"cert_number": "20180102686",
"changes": "",
"disclosure_date": "2018-03-16",
"first_cert_date": "2001-03-30",
"no": "11",
"type": "연구개발유형",
"valid_period": "2018-03-12 ~ 2020-03-11"
},
{
"cert_number": "20200102673",
"changes": "",
"disclosure_date": "2020-03-10",
"first_cert_date": "2001-03-30",
"no": "12",
"type": "연구개발유형",
"valid_period": "2020-03-12 ~ 2022-03-11"
},
{
"cert_number": "20220331020032",
"changes": "",
"disclosure_date": "2022-03-31",
"first_cert_date": "2001-03-30",
"no": "13",
"type": "연구개발유형",
"valid_period": "2022-03-12 ~ 2025-03-11"
},
{
"cert_number": "20250318020021",
"changes": "",
"disclosure_date": "2025-03-18",
"first_cert_date": "2001-03-30",
"no": "14",
"type": "연구개발유형",
"valid_period": "2025-03-12 ~ 2028-03-11"
}
],
"company_name": "테고사이언스주식회사",
"corp_no": "160111-*******",
"financials": {
"2022": {
"capital_stock": 4054417000,
"cost_of_sales": 1953512000,
"current_assets": 27165789000,
"current_liabilities": 1205230000,
"gross_profit": 5061108000,
"net_income": 279680000,
"net_income_bs": 334094000,
"non_current_assets": 23894653000,
"non_current_liabilities": 286622000,
"non_operating_expenses": 590037000,
"non_operating_income": 600467000,
"operating_profit": 269250000,
"revenue": 7014619000,
"sga_expenses": 4791858000,
"total_assets": 51060442000,
"total_equity": 49568590000,
"total_liabilities": 1491852000
},
"2023": {
"capital_stock": 4054417000,
"cost_of_sales": 2335430000,
"current_assets": 28008790000,
"current_liabilities": 654671000,
"gross_profit": 4888890000,
"net_income": -2370752000,
"net_income_bs": -2151010000,
"non_current_assets": 20667128000,
"non_current_liabilities": 414027000,
"non_operating_expenses": 2534988000,
"non_operating_income": 1205871000,
"operating_profit": -1041635000,
"revenue": 7224320000,
"sga_expenses": 5930525000,
"total_assets": 48675918000,
"total_equity": 47607220000,
"total_liabilities": 1068698000
}
},
"industry": "기초 의약 물질 제조업",
"investment": [
{
"amount": "187,747,000",
"changes": "187,747,000",
"date": "2006-02-27"
}
],
"main_products": "피부세포치료제 제조,도매,연구개발",
"phone": "02-818-****",
"years": [
2023,
2022
]
}Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |